Women who start having hot flashes in their 40s and early 50s had signs of poorer blood vessel health in a recent study and may be at a higher risk of cardiovascular disease later on, researchers say.
Politicians who attack the EU agency that ruled the weedkiller glyphosate probably does not cause cancer are in danger of undermining the effectiveness of a body that is key to keeping Europeans safe, its chief warned.
High school athletes with access to a certified athletic trainer are more knowledgeable about concussions and their consequences, but that doesn’t make them more likely to report a concussion, a U.S. study finds.
Canadian drugmaker Valeant Pharmaceuticals International Inc said it had priced its recently approved plaque psoriasis treatment at US$3,500 per month, ahead of an expected U.S. launch in the second half of 2017.
The number of people dying from hepatitis is rising, and most of the 325 million infected are unaware they have the virus and lack access to potentially life-saving medicines, the World Health Organization said on Friday.
When a badly injured patient rolls into the emergency room, Dr. John Scott doesn’t ask to see proof of insurance. Instead, he immediately begins treatment.
GlaxoSmithKline must pay US$3 million to a woman who sued the drug company over the death of her husband, a lawyer who committed suicide after taking a generic version of the antidepressant Paxil, a U.S. jury said on Thursday.
For people with type 2 diabetes, maintaining good blood sugar control in the years after receiving a coronary artery stent is associated with a lower risk of heart attack and stroke, according to a recent study.
Women who have been sexually assaulted in the U.S. often bear some costs for testing and other medical treatment when they report the rape to authorities, according to a new study.
Teva Pharmaceutical Industries Ltd on Thursday launched an asthma inhaler that will be the first direct competition to GlaxoSmithKline's best-selling Advair.